Clinical Trial Update: A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating vedolizumab in children and teenagers with moderate to severe Crohn's disease is currently recruiting. The study is sponsored …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Entyvio (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Crohn's Disease (CD) | Phase 3 | Status: RECRUITING